BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34216800)

  • 1. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism.
    Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X
    Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
    Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
    Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
    Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
    Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
    Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center.
    He Y; Li J; Zheng J; Khan Z; Qiang W; Gao F; Zhao Y; Shi B
    J Endocrinol Invest; 2017 Jul; 40(7):733-740. PubMed ID: 28236218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.
    Rabelo PN; Rabelo PN; Paula AF; Conceição SAD; Viggiano DPPO; Antunes DE; Jatene EM; Paula SLFM; Dias ML; Reis MAL
    Rev Assoc Med Bras (1992); 2019 Jul; 65(6):755-760. PubMed ID: 31340298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
    Bukhari S; Khan M; Kumar N; Mohan V
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Risk of Antithyroid Drug Agranulocytosis Associated with Amiodarone-Induced Thyrotoxicosis: A Population-Based Cohort Study.
    Gershinsky M; Saliba W; Lavi I; Shapira C; Gronich N
    Thyroid; 2019 Feb; 29(2):193-201. PubMed ID: 30648930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
    Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-day thionamide withdrawal prior to radioiodine uptake sufficiently increases uptake and does not exacerbate hyperthyroidism compared to 7-day withdrawal in Graves' disease.
    Kubota S; Ohye H; Yano G; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Kuma K; Miyauchi A
    Endocr J; 2006 Oct; 53(5):603-7. PubMed ID: 16896267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
    Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis.
    Yang J; Zhong J; Xiao XH; Zhou LZ; Chen YJ; Liu JH; Cao RX; Wen GB
    Endocr J; 2013; 60(2):185-9. PubMed ID: 23117149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization to Methimazole.
    Mazhari A; Emanuele MA; Espiritu B
    Endocr Pract; 2021 Mar; 27(3):185-190. PubMed ID: 33779553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
    Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D
    J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J; Gabalec F; Svilias I; Horáček J
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports.
    Kozielewicz D; Karwowska K; Dybowska D; Halota W
    Endokrynol Pol; 2012; 63(1):52-5. PubMed ID: 22378098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent agranulocytosis induced by two different antithyroid agents.
    Chen B; Lang R; Jutrin Y; Ravid M
    Med J Aust; 1983 Jul; 2(1):38-9. PubMed ID: 6865827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Report of Three Girls with Antithyroid Drug-Induced Agranulocytosis; Retrospective Analysis of 18 Cases Aged 15 Years or Younger Reported between 1995 and 2009.
    Minamitani K; Oikawa J; Wataki K; Kashima K; Hoshi M; Inomata H; Ota S
    Clin Pediatr Endocrinol; 2011 Apr; 20(2):39-46. PubMed ID: 23926393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.